- Home
- TLSI vs PESI Comparison
TLSI vs PESI Comparison
Compare TLSI & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- PESI
- Stock Information
- Founded
- TLSI 2010
- PESI 1990
- Country
- TLSI United States
- PESI United States
- Employees
- TLSI N/A
- PESI N/A
- Industry
- TLSI Medical Specialities
- PESI Environmental Services
- Sector
- TLSI Health Care
- PESI Industrials
- Exchange
- TLSI Nasdaq
- PESI Nasdaq
- Market Cap
- TLSI 124.9M
- PESI 191.9M
- IPO Year
- TLSI N/A
- PESI 1992
- Fundamental
- Price
- TLSI $4.69
- PESI $10.68
- Analyst Decision
- TLSI Strong Buy
- PESI Strong Buy
- Analyst Count
- TLSI 6
- PESI 1
- Target Price
- TLSI $11.75
- PESI $18.00
- AVG Volume (30 Days)
- TLSI 36.4K
- PESI 139.0K
- Earning Date
- TLSI 11-14-2024
- PESI 03-12-2025
- Dividend Yield
- TLSI N/A
- PESI N/A
- EPS Growth
- TLSI N/A
- PESI N/A
- EPS
- TLSI N/A
- PESI N/A
- Revenue
- TLSI $26,891,000.00
- PESI $67,134,000.00
- Revenue This Year
- TLSI $60.96
- PESI N/A
- Revenue Next Year
- TLSI $53.65
- PESI $52.66
- P/E Ratio
- TLSI N/A
- PESI N/A
- Revenue Growth
- TLSI 67.90
- PESI N/A
- 52 Week Low
- TLSI $3.50
- PESI $7.63
- 52 Week High
- TLSI $10.42
- PESI $16.25
- Technical
- Relative Strength Index (RSI)
- TLSI 51.68
- PESI 40.98
- Support Level
- TLSI $4.72
- PESI $10.10
- Resistance Level
- TLSI $5.32
- PESI $10.79
- Average True Range (ATR)
- TLSI 0.31
- PESI 0.51
- MACD
- TLSI 0.01
- PESI 0.07
- Stochastic Oscillator
- TLSI 47.52
- PESI 46.03
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: Treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.